Dilated Cardiomyopathy Clinical Trials

ReadTheTrial indexes 2 studies for Dilated Cardiomyopathy. The most common development stage is N/A (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Dilated Cardiomyopathy.

Pipeline by Phase

PhaseTrialsDistribution
N/A 1
50%
Phase 2 1
50%

Trial Status Breakdown

Trials for Dilated Cardiomyopathy

Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy: a Prospective Multi-centre Observational Study

NCT03843255 · ACTIVE NOT RECRUITING · N/A

Phase II Study Assessing the Combined Use of Autologous Bone Marrow Derived Mononuclear Cells and G-csf With Percutaneous Circulatory Assistance in the Treatment of Dilated Cardiomyopathy

NCT03572660 · ACTIVE NOT RECRUITING · Phase 2

Frequently Asked Questions

What clinical trials are available for Dilated Cardiomyopathy?

There are 2 clinical trials listed for Dilated Cardiomyopathy. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Dilated Cardiomyopathy trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Dilated Cardiomyopathy trials in?

Current Dilated Cardiomyopathy trials are distributed across: N/A (1), Phase 2 (1).

Find More Trials